Antiglycolipid Immunity

Possible Viral Etiology of Multiple Sclerosis
  • H. E. Webb
Part of the Infectious Agents and Pathogenesis book series (IAPA)


The concept that infection plays a part in the pathogenesis of Multiple Sclerosis (MS) has been considered for over 100 years.1 It is therefore appropriate to review the evidence to see why this concept is still very much in the forefront of present-day investigation into the etiology of this disease and to look at new ideas that might contribute to solving this elusive problem.


Multiple Sclerosis Multiple Sclerosis Patient Myelin Basic Protein Measle Virus Experimental Allergic Encephalomyelitis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marie, P., 1884, Sclerose en plaque et maladies infectieuses, Prog. Med. 12:287–289.Google Scholar
  2. 2.
    Kurtzke, J. E, 1983, Epidemiology of multiple sclerosis, in: Multiple Sclerosis (J. F. Hallpike, C. W. M. Adams, and W. W. Tourtellotte, eds.), Chapman and Hall, London, pp. 47–95.Google Scholar
  3. 3.
    Adams, J. M., and Imagawa, D. T., 1962, Measles antibodies in multiple sclerosis, Proc. Soc. Exp. Biol. Med. 111:562–566.PubMedGoogle Scholar
  4. 4.
    Adams, J. M., Brooks, M. B., Fisher, E. D., and Tyler, C. S., 1970, Measles antibodies in patients with multiple sclerosis and with other neurological and non-neurological diseases, Neurology 20:1039–1042.PubMedGoogle Scholar
  5. 5.
    Salmi, A. A., Norrby, E., and Panelius, M., 1972, Identification of different measles virusspecific antibodies in the serum and cerebrospinal fluid from patient with subacute sclerosing panencephalitis and multiple sclerosis, Infect. Immun. 6:248–254PubMedGoogle Scholar
  6. 6.
    Haire, M., 1977, Significance of virus antibodies in multiple sclerosis, Br. Med. Bull. 33:40–44.PubMedGoogle Scholar
  7. 7.
    Catalano, L. W, Jr., 1972, Herpesvirus hominis antibody in multiple sclerosis and amyotrophic lateral sclerosis, Neurology 22:473–478.PubMedGoogle Scholar
  8. 8.
    Cook, S. D., Dowling, P. C., and Russell, W. C., 1979, Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis, J. Neurol. Sci. 41:61–70.PubMedGoogle Scholar
  9. 9.
    Horikawa, Y., Tsubaki, T., and Nakajima, M., 1973, Rubella antibody in multiple sclerosis, Lancet 1:996–997.PubMedGoogle Scholar
  10. 10.
    Burks, J. S., Devald-Macmillan, B., Jankovsky, L., and Gerdes, J., 1979, Characterization of coronaviruses isolated using multiple sclerosis autopsy brain material, Neurology 29:547.Google Scholar
  11. 11.
    Norrby, E., Link, H., Olsson, J. E., Panelius, M., Salmi, A. G., and Vandvik, B., 1974, Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis, Infect. Immun. 10:688–694.PubMedGoogle Scholar
  12. 12.
    Cremer, N. E., Johnson, K. P., Fein, G., and Litosky, W. H., 1980, Comprehensive viral immunology of multiple sclerosis II. Analysis of serum and CSF antibodies by standard serologic methods, Arch. Neurol. 37:610–615.PubMedGoogle Scholar
  13. 13.
    Goswami, K. K. A., Randall, R. E., Lange, L. S., and Russell, W C., 1987, Antibodies against the paramyxovirus SV5 in cerebrospinal fluids of some multiple sclerosis patients, Nature 327:244–246.PubMedGoogle Scholar
  14. 14.
    Salmi, A., Reunanen, M., Ilonens, J., and Panelius, M., 1983, Intrathecal antibody synthesis to virus antigens in multiple sclerosis, Clin. Exp. Immunol. 52:241–249.PubMedGoogle Scholar
  15. 15.
    Arnadottir, T., Reunanen, M., and Salmi, A., 1982, Intrathecal synthesis of virus antibodies in multiple sclerosis patients, Infect. Immun. 38:399–407.PubMedGoogle Scholar
  16. 16.
    Vandvik, B., Norrby, E., Nordal, H., and Degre, M., 1976, Oligoclonal measles virus specific IgG antibodies isolated by virus immunoabsorption of cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis, Scand. j Immunol. 5:979–992.PubMedGoogle Scholar
  17. 17.
    Nordal, H. J., Vandvik, B., and Norrby, E., 1978, Multiple sclerosis: Local synthesis of electrophoretically restricted measles, rubella, mumps and herpes simplex virus antibodies in the central nervous system, Scand. J. Immunol. 7(6):473–479.PubMedGoogle Scholar
  18. 18.
    Gudnadottir, M., Helgadottir, H., Bjarnason, O., and Jonsdottir, K., 1964, Virus isolated from the brain of a patient with multiple sclerosis, Exp. Neurol. 9:85–95.PubMedGoogle Scholar
  19. 19.
    Meulenter, V., Koprowski, H., Iwasaki, Y., Kackell, Y. M., and Muller, D., 1972, Fusion of cultured multiple-sclerosis brain cells with indicator cells: Presence of nucleocapsids and virion and isolation of parainfluenza-type virus, Lancet 1:1–5.Google Scholar
  20. 20.
    Burks, J. S., DeVald, B. L., Jankovsky, L. D., and Gerdes, J. C., 1980, Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients, Science 209: 933–934.PubMedGoogle Scholar
  21. 21.
    Prineas, J., 1972, Paramyxovirus-like particles associated with acute demyelination in chronic relapsing multiple sclerosis, Science 178:760–763.PubMedGoogle Scholar
  22. 22.
    Pathak, S., and Webb, H. E., 1976, Paramyxovirus-like inclusions in brain of patient with severe multiple sclerosis, Lancet 2:311.PubMedGoogle Scholar
  23. 23.
    Webb, H. E., and Fazakerley, J. K., 1984, Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis? Neuropathol. App. Neurobiol. 10: 1–10.Google Scholar
  24. 24.
    Pathak, S., and Webb, H. E., 1974, Possible mechanisms for the transport of Semliki Forest virus into and within mouse brain, J. Neurol. Sci. 23:175–184.PubMedGoogle Scholar
  25. 25.
    Rodriguez, M., Pease, L. R., and David, C. S., 1986, Immune-mediated injury of virus-infected oligodendrocytes, Immunol. Today 7(12):359–362.Google Scholar
  26. 26.
    Rogers, N. G., Basnight, M., Gibbs, C. J., Jr., and Gajdusek, D. C., 1967, Latent viruses in chimpanzees with experimental kuru, Nature 216:446–449.PubMedGoogle Scholar
  27. 27.
    Fujinami, R. S., and Oldstone, M. B. A., 1985, Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity, Science 230:1043–1045.PubMedGoogle Scholar
  28. 28.
    Tardieu, M., Powers, M., Hafler, D. A., Hauser, S. L., and Weiner, H. L., 1984, Autoimmunity following viral infection: Demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes, Eur. J. Immunol. 14:561–565.PubMedGoogle Scholar
  29. 29.
    Lane, D. P., and Hoeffler, W. K., 1980, SV40 large T shares an antigenic determinant with a cellular protein of molecular weight 68,000, Nature 288:167–170.PubMedGoogle Scholar
  30. 30.
    Fujinami, R. S., Oldstone, M. B. A., Wroblewska, Z., Frankel, M. E., and Koprowski, H., 1983, Molecular mimicry in virus infection: Cross reaction of measle virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments, Proc. Natl. Acad. Sci. U.S.A. 80:2346–2350.PubMedGoogle Scholar
  31. 31.
    Jahnke, U., Fischer, E. H., and Alvord, E. C., Jr., 1985, Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis, Science 229:282–284.PubMedGoogle Scholar
  32. 32.
    Kagnoff, M. E, Austin, R. K., Hubert, J. J., Bernardin, J. E., and Kasarda, D. D., 1984, Possible role for a human adenovirus in the pathogenesis of celiac disease, J. Exp. Med. 160: 1544–1557.PubMedGoogle Scholar
  33. 33.
    Srinivasappa, J., Saegusa, J., Prabhakar, B. S., Gentry, M. K., Buchmeier, M. J., Wiktor, T. J., Koprowski, H., Oldstone, M. B. A., and Notkins, A. L., 1986, Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues, j Virol. 57: 397–401.PubMedGoogle Scholar
  34. 34.
    Miller, S. D., Clatch, R. J., Pevear, D. C., Trotter, J. L., and Lipton, H. L., 1987, Class II-restricted T cell responses in Theiler’s murine encephalomyelitis virus (TMEV)-induced demyelinating disease, J. Immunol. 138:3776–3784.PubMedGoogle Scholar
  35. 35.
    Bahmanyar, S., Srinivasappa, J., Casali, P., Fujinami, R. S., and Oldstone, M. B. A., 1987, Antigenic mimicry between measles and human T lymphocytes, J. Infect. Dis. 156:526–527.Google Scholar
  36. 36.
    Haspel, M. V, Onodera, T., Prabhakar, B. S., Horita, M., Suzuki, H., and Notkins, A. L., 1983, Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine tissues, Science 230:304–306.Google Scholar
  37. 37.
    Huber, S. A., and Lodge, P. A., 1984, Coxsackie virus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens, Am. J Pathol. 116:21–29.PubMedGoogle Scholar
  38. 38.
    Paterson, P. Y., 1976, Experimental autoimmune (allergic) encephalomyelitis. Induction, pathogenesis and suppression, in: Textbook of Immunopathology (P. A. Miescher and J. J. Mueller-Eberhard, eds.), Grune & Stratton, New York, pp. 225–251.Google Scholar
  39. 39.
    Raine, C. S., Traugott, V., Iqbal, K., Snyder, D. S., Cohen, S. R., Farooq, M., and Norton, W. T., 1978, Encephalitogenic properties of purified preparations of bovine oligodendrocytes tested in guinea pigs, Brain Res. 142:85–96.PubMedGoogle Scholar
  40. 40.
    Tabara, T., and Endoh, M., 1985, Humoral immune response to myelin basic protein, cerebroside and ganglioside in chronic relapsing experimental allergic encephalomyelitis of the guinea pig, J. Neurol. Sci. 67:201–212.Google Scholar
  41. 41.
    Raine, C. S., Traugott, U., Farooq, M., Bornstein, M. B., and Norton, W. T., 1981, Augmentation of immune-mediated demyelination by lipid haptens, Lab. Invest. 45: 174–182.PubMedGoogle Scholar
  42. 42.
    Hoffman, P.M., Gaston, D. D., and Spitler, L. E., 1973, Comparison of experimental allergic encephalomyelitis induced with spinal cord, basic protein, and synthetic encephalitogenic peptide, Clin. Immunol. Immunopathol. 1:364–371.PubMedGoogle Scholar
  43. 43.
    Paterson, P. Y., 1977, Autoimmune neurological disease: Experimental animal system and implication for multiple sclerosis, in: Autoimmunity (N. Talai, ed.), Academic Press, New York, p. 658.Google Scholar
  44. 44.
    Dubois-Dalcq, M., Niedieck, B., and Buyse, M., 1970, Action of anti-cerebroside sera on myelinated nervous tissue cultures, Pallid. Eur. 5:331–347.Google Scholar
  45. 45.
    Fry, J. M., Weissbarth, S., Lehrer, G. M., and Bornstein, M. B., 1974, Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue cultures, Science 183:540–542.PubMedGoogle Scholar
  46. 46.
    Maggio, B., and Cumar, E. A., 1975, Experimental allergic encephalomyelitis: Dissociation of neurological symptoms from lipid alterations in brain, Nature 253:364–365.PubMedGoogle Scholar
  47. 47.
    Seil, E. J., Falk, G. A., Kies, M. W, and Alvord, E. C., 1968, The in vitro activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen, Exp. Neurol. 22: 545–555.PubMedGoogle Scholar
  48. 48.
    Saida, T, Saida, K., and Silberberg, D. H., 1979, Demyelination produced by experimental allergic neuritis serum and antigalactocerebroside antiserum in CNS cultures: An ultra-structural study, Acta. Neuropathol. (Berl.) 48:19–25.Google Scholar
  49. 49.
    Zamvil, S. S., Nelson, P. A., Mitchell, D. J., Knobler, R. L., Fritz, R. B., and Steinman, L., 1985, Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition, J. Exp. Med. 162:2107–2124.PubMedGoogle Scholar
  50. 50.
    Watanabe, R., Wege, H., and ter Meulen, V., 1983, Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis, Nature 305:150–153.PubMedGoogle Scholar
  51. 51.
    Gasser, D. L., Newlin, C. M., Palm, J., and Gomatas, N. K., 1973, Genetic control of susceptibility to experimental allergic encephalomyelitis in rats, Science 181:872–873.PubMedGoogle Scholar
  52. 52.
    Williams, R. H., and Moore, M. J., 1973, Linkage of susceptibility to experimental allergic encephalomyelitis to the major histocompatibility locus in the rat, j Exp. Med. 138: 775–783.PubMedGoogle Scholar
  53. 53.
    Levine, S., and Sowinski, R., 1975, Allergic encephalomyelitis in the reputedly resistant brown Norway strain of rats, J. Immunol. 114:597–601.PubMedGoogle Scholar
  54. 54.
    Tsukada, N., Koh, C.-S., Yanagisawa, N., Okano, A., Behan, W. M. H., and Behan, P. 0., 1987, A new model for multiple sclerosis: Chronic experimental allergic encephalomyelitis induced by immunization with cerebral endothelial cell membrane, Acta. Neuropathol. (Berl.) 73:259–266.Google Scholar
  55. 55.
    Maida, E., 1983, Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: Preliminary findings, J. Neurol. 229:103–111.PubMedGoogle Scholar
  56. 56.
    Leibowitz, S., and Gregson, N. A., 1979, Brain glycolipids as cell-surface antigens, in: Clinical Neuroimmunology (E C. Rose, ed.), Blackwell Scientific Publications, London, pp. 29–41.Google Scholar
  57. 57.
    Landsteiner, K., 1947, The specificity of Serological Reactions, Harvard University Press, Cambridge, pp. 210–240.Google Scholar
  58. 58.
    Leibowitz, S., Morgan, R. S., Berkinshaw-Smith, E. M. I., and Payling-Wright, G., 1961, Cerebral vascular damage in guinea-pigs induced by various heterophile antisera injected by the Forssman intracarotid technique, Br. J. Exp. Pathol. 42:455–463.PubMedGoogle Scholar
  59. 59.
    Klenk, E., 1969, On cerebrosides and gangliosides, in: Progress in the Chemistry of Fats and Other Lipids, Volume 10, Part 4 (R. T. Holman, ed.), Pergamon, New York, pp. 411–431.Google Scholar
  60. 60.
    Niedieck, B., and Palacios, O., 1965, Uber die Produktion von Cerbrosidantikorpern nach intradermaler Injection v.n Cerebrosid-Protein-Adjuvans-Emulsionen, Z. Immun. Forsch. 129:234–243.Google Scholar
  61. 61.
    Czeonkowska, A., and Leibowitz, S., 1974, The effect of homologous and heterologous carriers on the immunogenicity of the galactocerebroside hapten, Immunology 27:1117–1126.Google Scholar
  62. 62.
    Rapport, M. M., Graft, L., and Yariv, J., 1961, Immunochemical studies of organs and tumor lipids. IX. Configuration of the carbohydrate residues in cytolipin H, Arch. Biochem. Biophys. 92:438–440.PubMedGoogle Scholar
  63. 63.
    Arnon, R., Crisp, E., Kelly, R., Ellison, S. W, Myes, L. W, and Tourtellotte, W. W, 1980, Anti-ganglioside antibodies in multiple sclerosis, J. Neurol. Sci. 26:179–186.Google Scholar
  64. 64.
    Kasai, N., Pachner, A. R., and Yu, R. K., 1986, Anti-glycolipid antibodies and their immune complexes in multiple sclerosis, J. Neurol. Sci. 75:33–42.PubMedGoogle Scholar
  65. 65.
    Duponey, R., 1972, Role of the cerebrosides and a galactodiglyceride in the antigenic cross reaction between nerve tissue and treponema, J. Immunol. 109:146–153.Google Scholar
  66. 66.
    Offner, H., Konat, G., and Sela, B.-A., 1981, Multi-sialo brain gangliosides are powerful stimulators of active E-rosetting lymphocytes from multiple sclerosis patients, J. Neurol. Sci. 52:279–287.PubMedGoogle Scholar
  67. 67.
    Sela, B.-A., Konat, A. B., and Offner, H., 1982, Elevated ganglioside concentration in serum and peripheral blood lymphocytes from multiple sclerosis patients in remission, J. Neurol. Sci. 54:143–148.PubMedGoogle Scholar
  68. 68.
    Ilyas, A. A., and Davison, A. N., 1983, Cellular hypersensitivity to gangliosides and myelin basic protein in multiple sclerosis, J. Neurol. Sci. 59:85–95.PubMedGoogle Scholar
  69. 69.
    Davison, A. M., and Ilyas, A. A., 1982, Cyclosporin A inhibits ganglioside-stimulated lymphocyte rosette formation in multiple sclerosis, Int. Arch. Allergy Appi. Immunol. 69:393–396.Google Scholar
  70. 70.
    Bellamy, A., Davison, A. N., and Feldmann, M., 1986, Derivation of ganglioside-specific T-cell lines of suppressor or helper phenotype from cerebrospinal fluid of multiple sclerosis patients, J. Neuroimmunol. 12:107–120.PubMedGoogle Scholar
  71. 71.
    Harboe, A., Schoyen, R., and Bye-Hansen, A., 1966, Haemagglutination inhibition by antibody to host material of fowl plague virus grown in different tissues of chick chorioallantoic membranes, Acta Pathol. Microbiol. Scand. 67:573–578.PubMedGoogle Scholar
  72. 72.
    Feinsod, F. M., Spielman, A., and Swaner, J. L., 1975, Neutralization of Sindbis virus by antisera to antigens of vector mosquitoes, Am. J. Trop. Med. Hyg. 24:533–536.PubMedGoogle Scholar
  73. 73.
    Almeida, J. D., and Waterson, A. P., 1969, The morphology of virus antibody interaction, Adv. Virus Res. 15:307–338.PubMedGoogle Scholar
  74. 74.
    Reilly, C. A., Jr., and Schloss, G. T, 1971, The erythrocyte as virus carrier in Friend and Rauscher virus leukemias, Cancer Res. 31:841–846.PubMedGoogle Scholar
  75. 75.
    Cox, K. O., and Keast, D., 1973, Rauscher virus infection, erythrocyte clearance studies, and autoimmune phenomena, J. Natl. Cancer Inst. 50:941–946.Google Scholar
  76. 76.
    Steck, A. J., Tschannen, R., and Schaefer, R., 1981, Induction of antimyelin and antioligodendrocyte antibodies by vaccinia virus—an experimental study in the mouse, J Neuroimmunol. 1:117–124.PubMedGoogle Scholar
  77. 77.
    Lindenmann, J., and Klein, P. A., 1967, Viral oncolysis: Increased immunogenicity of host cell antigen associated with influenza virus, J. Exp. Med. 126:93–108.PubMedGoogle Scholar
  78. 78.
    Rook, G. A. W, and Webb, H. E., 1970, Anti-lymphocyte serum and tissue culture used to investigate the role of cell-mediated response in viral encephalitis in mice, Br. Med. J. 4:210–212.PubMedGoogle Scholar
  79. 79.
    Madrid, R. E., Wisniewski, H. M., Iqbal, K., Pullarkat, R. K., and Lassmann, H., 1981, Relapsing experimental allergic encephalomyelitis induced with isolated myelin and with myelin basic protein plus myelin lipids, J. Neurol. Sci. 50:399–411.PubMedGoogle Scholar
  80. 80.
    Nagai, Y., Momoi, T., Saito, M., Mitzuzawa, E., and Ohtani, S., 1976, Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain ganglioside, Neurosci. Lett. 2:107–111.PubMedGoogle Scholar
  81. 81.
    Saida, T, Saida, K., Dorfman, S., Siblerger, D. H., Summer, A. J., Manning, M. C., Lisak, R. P., and Brown, M. N., 1979, Experimental allergic neuritis induced by sensitization with galactocerebrosides, Science 204:1103–1106.PubMedGoogle Scholar
  82. 82.
    Konat, G., Offner, H., Lev-Ram, V., Cohen, O., Schwartz, M., Cohen, I. R., and Sela, B.-A., 1982, Abnormalities in brain myelin of rabbits with experimental auto-immune multiple sclerosis-like disease induced by immunization to gangliosides, Acta Neurol. Scand. 66:568–574.PubMedGoogle Scholar
  83. 83.
    Hughes, R. A. C., and Powell, H. C, 1984, Experimental allergic neuritis: Demyelination induced by P2 alone and non-specific enhancement by cerebroside, J. Neuropathol. Exp. Neurol. 43:154–161.PubMedGoogle Scholar
  84. 84.
    Carroll, W. M., Jennings, A. R., and Mastaglia, E. L., 1984, Experimental demyelinating optic neuropathy induced by intra neural injection of galactocerebroside antiserum, J. Neurol. Sci. 65:125–135.PubMedGoogle Scholar
  85. 85.
    Roth, G. A., Royitta, M., Yu, R. K., Raine, C. S., and Bornstein, M. B., 1984, Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures, Brain Res. 339:9–18.Google Scholar
  86. 86.
    Sergott, R. C., Brown, M. J., Silberberg, D., and Lisak, R P., 1984, Antigalactocerebroside serum demyelinates optic nerve in vivo, J Neurol. Sci. 64:297–303.PubMedGoogle Scholar
  87. 87.
    Nakajima, H., and Ohara, J., 1967, Physico-chemical studies of Newcastle disease virus 3. The content of virus nucleic acid and its sedimentation pattern, Arch. Gem. Virusforsch. 20: 287–295.Google Scholar
  88. 88.
    Klenk, H. D., and Choppin, P. W, 1970, Glycosphingolipids of plasma membrane of cultured cells and an enveloped virus (SV5) grown in these cells, Proc. Natl. Acad. Sci. U.S.A. 66:57–64.PubMedGoogle Scholar
  89. 89.
    Soule, D. W, Marinetti, G. V., and Morgan, H. R., 1959, Studies of the hemolysis of red blood cells by mumps virus. IV. Quantitative study of changes in red blood lipids and of virus lipids, J. Exp. Med. 110:93–102.PubMedGoogle Scholar
  90. 90.
    Kates, M., Allison, A. C., Tyrrell, D. A. J., and James, A. T., 1961, Lipids of influenza virus and their relation to those of the host cell, Biochim. Biophys. Acta 52:455–466.Google Scholar
  91. 91.
    Blough, H. A., and Merlie, J. P., 1970, The lipids of incomplete influenza virus, Virology 40: 685–692.PubMedGoogle Scholar
  92. 92.
    Hirschberg, C. B., and Robbins, P. W, 1974, The glycolipids and phospholipids of Sindbis virus and their relation to the lipids of the host cell plasma membrane, Virology 61:602–608.PubMedGoogle Scholar
  93. 93.
    Quigley, J. P., Rifkin, D. B., and Reich, E., 1971, Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses, Virology 46:106–116.PubMedGoogle Scholar
  94. 94.
    Heydrick, E. P., Comer, J. E, and Wachter, R. E, 1971, Phospholipid composition of Venezuelan equine encephalitis virus, J. Virol. 7:642–645.PubMedGoogle Scholar
  95. 95.
    Renkonen, O., Kaarainen, L., Simons, K., and Gahmberg, C. G., 1971, The lipid class composition of Semliki Forest virus and of plasma membranes of the host cells, Virology 46: 318–326.PubMedGoogle Scholar
  96. 96.
    Laine, R., Kettunen, M. L., Gahmberg, C. G., Kääriäinen, L., and Renkonen, O., 1972, Fatty chains of different lipid classes of Semliki Forest virus and host cell membranes, J. Virol. 10:433–438.PubMedGoogle Scholar
  97. 97.
    Luukkonen, A., Kaariainen, L., and Renkonen, O., 1976, Phospholipids of Semliki Forest virus grown in cultured mosquito cells, Biochim. Biophys. Acta 450:109–120.PubMedGoogle Scholar
  98. 98.
    Webb, H. E., Chew Lim, M., Jagelman, S., Oaten, S. W, Pathak, S., Suckling, A. J., and MacKenzie, A., 1979, Semliki Forest virus infections in mice as a model for studying acute and chronic central nervous system virus infections in mice, in: Clinical Neuroimmunology (E. Rose, ed.), Blackwell Scientific Publications, London, pp. 369–390.Google Scholar
  99. 99.
    Khalili-Shirazi, A., Gregson, N., and Webb, H. E., 1986, Immunological relationship between a demyelinating RNA enveloped budding virus (Semliki Forest) and brain glycolipids, J. Neurol. Sci. 76:91–103.PubMedGoogle Scholar
  100. 100.
    Amor, S., and Webb, H. E., 1988, CNS pathogenesis following a dual virus infection with Semliki Forest (Alphavirus) and Langat (Flavivirus), Br. J. Exp. Pathol. 69:197–208.PubMedGoogle Scholar
  101. 101.
    Kelly, W. R., Blakemore, W. E, Jagelman, S., and Webb, H. E., 1982, Demyelination induced in mice by avirulent Semliki Forest virus. II. An ultrastructural study of focal demyelination in the brain, Neuropathol. Appi. Neurobiol. 8:43–53.Google Scholar
  102. 102.
    Illavia, S. J., Webb, H. E., and Pathak, S., 1982, Demyelination induced in mice by avirulent Semliki Forest virus. I. Virology and effects on optic nerve, Neuropathol. Appl. Neurobiol. 8: 35–42.PubMedGoogle Scholar
  103. 103.
    Jagelman, S., Suckling, A. J., Webb, H. E., and Bowen, E. T. W, 1978, The pathogenesis of avirulent Semliki Forest virus infections in athymic nude mice, J. Gen. Virol. 41:599–607.PubMedGoogle Scholar
  104. 104.
    Fazakerley, J. K., Amor, S., and Webb, H. E., 1983, Reconstitution of Semliki Forest virus infected mice, induces immune mediated pathological changes in the CNS, Clin. Exp. Immunol. 52:115–120.PubMedGoogle Scholar
  105. 105.
    Fazakerley, J. K., 1985, The role of the immune system in protection and pathogenesis during Semliki Forest virus encephalitis, Ph.D. Thesis, University of London.Google Scholar
  106. 106.
    Pathak, S., Illavia, S. J., and Webb, H. E., 1983, The identification and role of cells involved in CNS demyelination in mice after Semliki Forest virus infection: An ultrastructural study, Prog. Brain Res. 59:237–254.PubMedGoogle Scholar
  107. 107.
    Webb, H. E., Mehta, S., Leibowitz, S., and Gregson, N. A., 1984, Immunological reaction of the demyelinating Semliki Forest virus with immune serum to glycolipids and its possible importance to central nervous system viral auto-immune disease, Neuropathol. Appi. Neurobiol. 10:77–84.Google Scholar
  108. 108.
    Evans, N. R. S., and Webb, H. E., 1986, Immunoelectron microscopic labeling of glycolipids in the envelope of a demyelinating brain derived RNA virus (Semliki Forest) by antiglycolipid sera, J. Neurol. Sci. 74:279–287.PubMedGoogle Scholar
  109. 109.
    Khalili-Shirazi, A., Gregson, N., and Webb, H. E., 1988, Immunocytochemical evidence for Semliki Forest virus antigen persistence in mouse brain, J. Neurol. Sci. 85:17–26.PubMedGoogle Scholar
  110. 110.
    Amor, S., 1988, An investigation into mixed Toga and Flavi virus infections and their effect on the pathogenesis of CNS disease, Ph.D. Thesis, University of London.Google Scholar
  111. 111.
    Khalili-Shirazi, A., 1988, A study of the antigenicity of the host central nervous system derived glycolipids in the envelope of Semliki Forest virus, Ph.D. Thesis, University of London.Google Scholar
  112. 112.
    Pathak, S., Illavia, S. J., and Khalili-Shirazi, A., 1990, Immunoelectron microscopical labelling of a glycolipid in the envelopes of brain cell derived budding viruses, Semliki Forest, influenza and measles, using a monoclonal antibody directed chiefly against galactocerebroside made by SFV immunization, J. Neurol. Sci. 96:293–302.PubMedGoogle Scholar
  113. 113.
    Illavia, S. J., and Webb, H. E., 1988, The pathological effect on the central nervous system of mice following single and repeated infections of the demyelinating A7(74) strain of Semliki Forest virus, Neuropathol. Appi. Neurobiol. 14:207–220.Google Scholar
  114. 114.
    Bradish, C. J., and Allner, K., 1972, The early responses of mice to respiratory or intraperitoneal infection by defined virulent and avirulent strains of Semliki Forest virus, J. Gen. Virol. 15:205–218.PubMedGoogle Scholar
  115. 115.
    Zlotnik, I., Grant, D. P., and Batter-Hatton, D., 1972, Encephalopathy in mice following inapparent Semliki Forest virus infection, Br. J. Exp. Pathol. 53:125–129.PubMedGoogle Scholar
  116. 116.
    Hughes, R. A. C., Gray, I. A., Gregson, N. A., Kadlubowski, M., Kennedy, M., Leibowitz, S., and Thompson, H., 1984, Immune responses to myelin antigens in Guillain—Barré syndrome, J. Neuroimmunol. 6:303–312.PubMedGoogle Scholar
  117. 117.
    Allison, A. C., 1971, Unresponsiveness to self antigens, Lancet 2:401.Google Scholar
  118. 118.
    Roitt, I., 1980, Essential Immunology, Blackwell Scientific Publications, Oxford, pp. 306–309.Google Scholar
  119. 119.
    Rose, N. R., and Witebsky, E., 1968, Thyroid autoantibodies in thyroid disease, Adv. Metab. Dis. 3:231–277.Google Scholar
  120. 120.
    Marcus, D. M., and Schwarting, G. A., 1976, Immunochemical properties of glycolipids and phospholipids, Adv. Immunol. 23:203–240.PubMedGoogle Scholar
  121. 121.
    Rapport, M. M., and Graf, L., 1969, Immunochemical reactions of lipids, Prog. Allergy 13: 273–331.PubMedGoogle Scholar
  122. 122.
    Toy, J. L., 1983,The interferons, Clin. Exp. Immunol. 54:1–13.PubMedGoogle Scholar
  123. 123.
    Morris, A., Tomkins, P. T., Maudsley, D. J., and Blackman, M., 1987, Infection of cultured murine brain cells by Semliki Forest virus: Effects of interferon-p on viral replication, viral antigen display, major histocompatibility complex antigen display and lysis by cytotoxic T lymphocytes, J. Gen. Virol. 68:99–106.PubMedGoogle Scholar
  124. 124.
    Zinkernagel, R. M., and Doherty, P. C., 1979, MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction specificity, function and responsiveness, Adv. Immunol. 27:52–180.Google Scholar
  125. 125.
    Suzumura, A., Lavi, E., Weiss, S. R., and Silberberg, D. H., 1986, Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes, Science 232:991–993.PubMedGoogle Scholar
  126. 126.
    Wong, G. H. W, Bartlett, P. E, Clark-Lewis, I., Battye, E, and Schrader, J. W, 1984, Inducible expression of H-2 and la antigens on brain cells, Nature 310:688–691.PubMedGoogle Scholar
  127. 127.
    Massa, P. T, Dorries, R., and ter Meulen, V., 1986, Viral particles induce la antigen expression on astrocytes, Nature 320:543–546.PubMedGoogle Scholar
  128. 128.
    Kim, S. U., Moretto, G., and Shin, D. H., 1985, Expression of la antigens on the surface of human oligodendrocytes and astrocytes in culture, J. Neuroimmunol. 10(2):141–149.PubMedGoogle Scholar
  129. 129.
    Azocar, J., Essex, M., and Yunis, E. J., 1983, Cell culture density modulates the incorporation of HLA antigens by enveloped viruses, Hum. Immunol. 7:59–65.PubMedGoogle Scholar
  130. 130.
    Kabat, E. A., Wolf, A., and Bezer, A. E., 1949, Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys, J. Exp. Med. 89:395–398.PubMedGoogle Scholar
  131. 131.
    Martenson, E., 1969, Glycosphingolipids of animal tissues, in: Progress in the Chemistry of Fats and Other Lipids, Volume 10 (R. T Holman, ed.), Pergaman Press, Oxford, pp. 365–407.Google Scholar
  132. 132.
    Gregson, N. A., Kennedy, M., and Leibowitz, S., 1977, Gangliosides as surface antigens of cells isolated from rat cerebellar cortex, Nature 266:461–463.PubMedGoogle Scholar
  133. 133.
    Bornstein, M. B., and Raine, C. S., 1970, Experimental allergic encephalomyelitis in antiserum inhibition of myelination in vitro,Lab. Invest. 23:536–542.PubMedGoogle Scholar
  134. 134.
    Gregson, N. A., Pytharas, M., and Leibowitz, S., 1977, The reactivity of anti-ganglioside antiserum with isolated cerebellar cells, Biochem. Soc. Trans. 5:174–175.PubMedGoogle Scholar
  135. 135.
    Husby, G., Van De Rijn, I., Zabriskie, J. B., Abdin, Z. H., and Williams, R. C., Jr., 1976, Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever, J. Exp. Med. 144:1094–1110.PubMedGoogle Scholar
  136. 136.
    Biberfield, G., 1971, Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection, Clin. Exp. Immunol. 8:319–333.Google Scholar
  137. 137.
    Gessain, A., Barin, E, Varnant, J. C., Gout, O., Maurs, L., Calender, A., and De The, G., 1985, Antibodies to human T-lymphotrophic virus type I in patients with tropical spastic paraparesis, Lancet 2:407–409.PubMedGoogle Scholar
  138. 138.
    Roman, G. C., 1987, Retrovirus associated myelopathies, Arch. Neurol. 44(6):659–663.PubMedGoogle Scholar
  139. 139.
    Greene, W. C., Leonard, W. J., Wano, Y., Sveteik, P. B., Peffer, N. J., Sodroski, J. G., Rosen, C. A., Goh, W. C., and Haseltine, W. A., 1986, Trans-activator gene of HTLV II induces IL-2 receptor and IL-2 cellular gene expression, Science 232:877–880.PubMedGoogle Scholar
  140. 140.
    Sternberger, N. H., del Cerro, C., and Kies, M. W, 1985, Immunocytochemistry of myelin basic proteins in adult rats oligodendroglia, J. Neuroimmunol. 7:355–363.PubMedGoogle Scholar
  141. 141.
    Fujinami, R. S., Zurbriggen, A., and Powell, H. C., 1988, Monoclonal antibody defines determinant between Theiler’s virus and lipid-like structures, J Neuroimmunol. 20:25–32.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1992

Authors and Affiliations

  • H. E. Webb
    • 1
  1. 1.Department of Neurovirology,UMDS, The Rayne InstituteSt. Thomas’ HospitalLondonEngland

Personalised recommendations